Swiss Re AG (SWX:SREN)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 38.14B -4.3% |
| Revenue (ttm) | 34.00B -3.3% |
| Net Income | 3.89B +45.8% |
| EPS | 13.11 +44.2% |
| Shares Out | 294.10M |
| PE Ratio | 9.89 |
| Forward PE | 10.22 |
| Dividend | 6.42 (4.93%) |
| Ex-Dividend Date | Apr 14, 2026 |
| Volume | 599,714 |
| Open | 130.90 |
| Previous Close | 130.10 |
| Day's Range | 128.70 - 131.55 |
| 52-Week Range | 114.05 - 156.80 |
| Beta | 0.34 |
| Analysts | Sell |
| Price Target | 129.37 (-0.25%) |
| Earnings Date | Aug 6, 2026 |
About Swiss Re AG
Swiss Re AG, together with its subsidiaries, provides reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions segments. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit, surety and political, engineering and project, aviation, marine, agriculture, renewable energy, retakaful, and facultative reinsurance solutions; and... [Read more]
Financial Performance
In 2025, Swiss Re AG's revenue was $42.60 billion, a decrease of -4.17% compared to the previous year's $44.45 billion. Earnings were $4.62 billion, an increase of 45.20%.
Financial numbers in USD Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for SREN stock is "Sell." The 12-month stock price target is CHF 129.37, which is a decrease of -0.25% from the latest price.
News
Swiss Re AG Earnings Call Transcript: Q1 2026
Q1 2026 net income reached $1.5 billion with a 24% ROE, driven by strong underwriting and investment gains. P&C Re and Corporate Solutions delivered robust combined ratios, while Life & Health Re showed improved earnings and positive experience variance.
Swiss Re AG Slides: Q1 2026
Swiss Re AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Swiss Re AG Earnings release: Q1 2026
Swiss Re AG released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Swiss Re Net Profit Gets Boost From Lower Natural-Catastrophe Losses
The reinsurer said its property-and-casualty segment benefited from low large losses and its life-and-health segment from favorable U.S. mortality trends.
Iran war's Inflationary impact is the key risk to Asia insurers: Swiss Re
Paul Murray, CEO of Life and Health Reinsurance at Swiss Re, says inflation risks in Asia due to the Iran war and rising energy prices are a key concern for the insurance sector in the region. He also...
Swiss Re AG Transcript: AGM 2026
Record net income and strong capital position enabled a higher dividend and share buyback. Strategic focus on core business, technology, and sustainability was reaffirmed, with all board proposals and compensation motions approved. Shareholders raised climate and governance concerns.
Swiss Re AG Slides: Corporate presentation
Swiss Re AG has posted slides in relation to its latest quarterly earnings report, which was published on March 16, 2026.
Swiss Re AG Earnings Call Transcript: Q4 2025
Record net income of $4.8B and 20% ROE in 2025, with strong P&C and Corporate Solutions performance, robust capital returns, and a focus on resilience. Outlook for 2026 targets $4.5B net income and continued cost reductions.
Swiss Re AG Annual report: Q4 2025
Swiss Re AG has published its Q4 2025 annual report on February 27, 2026.
Swiss Re AG Earnings release: Q4 2025
Swiss Re AG released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.
Swiss Re AG Slides: Q4 2025
Swiss Re AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Swiss Re AG Earnings Call Transcript: Q4 2025
Record net income of $4.8B in 2025 exceeded targets, driven by strong underwriting, cost savings, and portfolio resilience. Shareholder returns rise with a $1.5B buyback and 9% dividend hike, while 2026 guidance reflects normalized catastrophe assumptions.
Swiss Re AG Earnings release: Q4 2025
Swiss Re AG released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.
Swiss Re AG Slides: Q4 2025
Swiss Re AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Swiss Re Profit Slips on Lower Revenue
The reinsurer posted a decline in fourth-quarter net profit on a softer top line, falling to $717 million from the $1.05 billion reported the year prior.
Swiss Re AG Transcript: Status Update
Management emphasizes disciplined growth, resilience, and technical excellence, targeting $4.5B net income and 20% ROE for 2026. Portfolio repositioning, cost reductions, and AI-driven transformation underpin performance, while a new $500M annual buyback complements a >7% dividend growth policy.
Swiss Re AG Press release: Status Update
Swiss Re AG issued a press release on December 5, 2025, disclosing material business information to investors.
Swiss Re AG Slides: Status Update
Swiss Re AG has posted slides in relation to its latest quarterly earnings report, which was published on December 5, 2025.
Swiss Re Targets Higher Profit in 2026; Sets Out Buyback Program
The group continues to aim for annual dividend per share growth of 7% or more over next two years and to complement this with an annual share buyback program starting in 2026.
Swiss Re AG Earnings Call Transcript: Q3 2025
Net income reached $4B for the first nine months, with strong P&C results and robust capital. Life & Health Re is expected to miss its full-year target due to negative assumption updates, but group guidance remains unchanged.
Swiss Re AG Earnings release: Q3 2025
Swiss Re AG released its Q3 2025 earnings on November 14, 2025, summarizing the period's financial results.
Swiss Re AG Slides: Q3 2025
Swiss Re AG has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 14, 2025.
Swiss Re Says Low Natural-Catastrophe Losses Lift Results
Net profit rose to $4 billion for the first nine months of the year, compared with $2.2 billion for the same prior-year period, when it took a hit from an increase in U.S. liability reserves.
Swiss Re says GLP-1 drugs could reduce US mortality by up to 6.4%
Reinsurance company Swiss Re said on Wednesday that widespread use of GLP-1 drugs to treat obesity could reduce the annual rate of death by up to 6.4% in the United States by 2045.
CORRECTING and REPLACING Best's Market Segment Report: Swiss Re's Adoption of IFRS 17 Shuffles the Top Tier in AM Best's “World's 50 Largest Reinsurers” Rankings
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--The figure for Berkshire Hathaway in the fourth paragraph should read: USD 26.9 billion (instead of USD 26.9 million). The updated release reads: BEST'S MA...